A Phase I Trial of Sarcosinamide Nitrosourea (SarCNU) in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2013
At a glance
- Drugs NSC 364432 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 31 Jan 2013 Actual end date Sep 2005 added as reported by ClinicalTrials.gov.
- 31 Jan 2013 Actual initiation date changed from Nov 1999 to Aug 1999 as reported by ClinicalTrials.gov.
- 11 Jan 2007 Status changed from in progress to completed